Add to ORKGUnderstanding and controlling the solid-state chemistry of active pharmaceutical ingredients (APIs) is an important aspect of drug development process. APIs can exist in a variety of distinct solid forms, including polymorphs, solvates, hydrates, salts, cocrystals and amorphous solids. Most APIs are purified and isolated by crystallization from a
The Breakthrough into solid-state research has become emerging approach for structure determination ...
Polymorphism, the ability of a substance to crystallize in two or more different structures, is a fu...
The cocrystal production and properties are intricate in different ways. It exhibits properties corr...
Many active pharmaceutical ingredients (APIs) can exist in more than one solid-state form, including...
Active pharmaceutical ingredients (APIs) are frequently delivered to the patient in the solid-state ...
The crystallisation of an active pharmaceutical ingredient (API) is a fundamental step in the manufa...
Crystal form (cocrystals, polymorphs, salts, hydrates and solvates) assortment remains a scientific ...
The selection of the crystalline phases in a form of molecular co-crystals has become scientific ch...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
In the solid state, the active pharmaceutical ingredients tend to exhibit crystalline order. In this...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
The pharmaceutical industry now routinely develops molecules with a molecular weight greater than 50...
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific p...
The Breakthrough into solid-state research has become emerging approach for structure determination ...
Polymorphism, the ability of a substance to crystallize in two or more different structures, is a fu...
The cocrystal production and properties are intricate in different ways. It exhibits properties corr...
Many active pharmaceutical ingredients (APIs) can exist in more than one solid-state form, including...
Active pharmaceutical ingredients (APIs) are frequently delivered to the patient in the solid-state ...
The crystallisation of an active pharmaceutical ingredient (API) is a fundamental step in the manufa...
Crystal form (cocrystals, polymorphs, salts, hydrates and solvates) assortment remains a scientific ...
The selection of the crystalline phases in a form of molecular co-crystals has become scientific ch...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
Abstract The selection of the crystalline phases in a form of molecular cocrystals has become scient...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
In the solid state, the active pharmaceutical ingredients tend to exhibit crystalline order. In this...
The selection of the crystalline phases in a form of molecular cocrystals has become scientific chal...
The pharmaceutical industry now routinely develops molecules with a molecular weight greater than 50...
Cocrystals can be used as an alternative approach based on crystal engineering to enhance specific p...
The Breakthrough into solid-state research has become emerging approach for structure determination ...
Polymorphism, the ability of a substance to crystallize in two or more different structures, is a fu...
The cocrystal production and properties are intricate in different ways. It exhibits properties corr...